We are delighted to share another interesting panel from the 17th Annual European Life Sciences CEO Forum (#Sachs_ELSF) - Pharma Dealmakers Panel: Viewing the Challenges from Both Sides. 🌐🤝

The panel included both biotech innovators and pharma giants - there is no better way to familiarize with both sides of pharma DealMaking!

Chaired by:
Sarah Holland, President of Swiss Healthcare Licensing Group & CBO, Cureteq AG
Panellists:
Alessandra Polara, Senior Director, Global BD, F. Hoffmann-La Roche AG
David Colpman, Director, Alpina Life Science Advisors
Emin Fadillioglu, CEO, Eczacibasi Pharmaceutical and Industrial Investment Co.
Peter Braun, CEO, TargImmune Therapeutics AG
Ulrich Wendt, Global Head Business Development Immunology & Inflammation, Sanofi

#PharmaDealmakers #Biopharma #LifeSciences #StrategicPartnerships #InvestmentStrategies #BiotechInnovation #PharmaIndustry #SachsForum #Sachs_ELSF #SachsSpringLifeSciencesWeek #SSLSW